These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 11184639)

  • 1. The impact of Abbott's consent decree on clinical laboratories.
    Assarian GS
    MLO Med Lab Obs; 2000 Sep; 32(9):56-8. PubMed ID: 11184639
    [No Abstract]   [Full Text] [Related]  

  • 2. Abbott Laboratories Consent Decree and individual responsibility under the Federal Food, Drug, and Cosmetic Act.
    Blumberg EM
    Food Drug Law J; 2000; 55(1):145-9. PubMed ID: 12322721
    [No Abstract]   [Full Text] [Related]  

  • 3. Medical device and Laboratory Product Problem Reporting Program (PRP).
    AANA J; 1979 Feb; 47(1):5. PubMed ID: 442931
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmaceutical industry wins "round one" in protections against product liability claims.
    Gatty B
    Hosp Formul; 1995 Apr; 30(4):238, 237. PubMed ID: 10141868
    [No Abstract]   [Full Text] [Related]  

  • 5. Laboratory controls--an FDA investigator's viewpoint.
    Avallone HL
    J Parenter Sci Technol; 1986; 40(5):178-82. PubMed ID: 3794896
    [No Abstract]   [Full Text] [Related]  

  • 6. Manufacturing misdeeds cost Abbott record-breaking payment.
    Lewis C
    FDA Consum; 2000; 34(3):38-9. PubMed ID: 11521253
    [No Abstract]   [Full Text] [Related]  

  • 7. Quality control practices and preferences in today's clinical laboratory. A report for government regulators, decision makers, and advisors.
    Cooper WG
    MLO Med Lab Obs; 1997 Jun; 29(6):56-7, 60, 62-5. PubMed ID: 10173036
    [No Abstract]   [Full Text] [Related]  

  • 8. Retesting and laboratory investigations.
    Davis JS
    J Pharm Sci Technol; 1994; 48(3):107-9. PubMed ID: 8069512
    [No Abstract]   [Full Text] [Related]  

  • 9. Litigation plays protective role--and is part of the problem.
    Kennett JD
    Mo Med; 2007; 104(1):12-3. PubMed ID: 17410818
    [No Abstract]   [Full Text] [Related]  

  • 10. AHI perspectives: flexible drug labeling and its impact on the drug development process. Liability issues.
    Thomas JW
    J Am Vet Med Assoc; 1995 Oct; 207(7):899-900; discussion 902-4. PubMed ID: 7559021
    [No Abstract]   [Full Text] [Related]  

  • 11. Can the Food and Drug Administration ensure that our pharmaceuticals are safely manufactured?
    Hubbard WK
    Arch Intern Med; 2009 Oct; 169(18):1655-6. PubMed ID: 19822821
    [No Abstract]   [Full Text] [Related]  

  • 12. Validation--mission completed?
    Sharp J
    J Parenter Sci Technol; 1993; 47(1):2-3. PubMed ID: 8445494
    [No Abstract]   [Full Text] [Related]  

  • 13. Con: competitive bidding cannot work in the clinical laboratory.
    Blanchard MR
    Clin Leadersh Manag Rev; 2006 Jul; 20(4):E3. PubMed ID: 16867292
    [No Abstract]   [Full Text] [Related]  

  • 14. Bitter medicine.
    Simons J
    Fortune; 2002 Oct; 146(7):169-70, 172, 174. PubMed ID: 12408039
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmaceutical GMPs.
    Bobrowicz G
    Qual Assur; 1994 Jun; 3(2):138-48. PubMed ID: 7804629
    [No Abstract]   [Full Text] [Related]  

  • 16. Tempered enthusiasm. Drug-safety law needs more teeth, patient-safety advocates say.
    DerGurahian J
    Mod Healthc; 2007 Oct; 37(40):16. PubMed ID: 18018373
    [No Abstract]   [Full Text] [Related]  

  • 17. New POCT (point-of-care testing) guide establishes testing uniformity.
    Goldsmith BM
    MLO Med Lab Obs; 1995 Aug; 27(8):50-2. PubMed ID: 10172406
    [No Abstract]   [Full Text] [Related]  

  • 18. Laboratory testing under the microscope: the Clinical Laboratory Improvement Amendments of 1988.
    Raskin RD
    J Health Hosp Law; 1992 Feb; 25(2):33-6, 63. PubMed ID: 10171349
    [No Abstract]   [Full Text] [Related]  

  • 19. Innovation and compliance are not diametrically opposed.
    Raab GK
    Qual Assur; 1994 Mar; 3(1):2-8. PubMed ID: 7804614
    [No Abstract]   [Full Text] [Related]  

  • 20. Total quality management: an application in a biomedical laboratory.
    Latzer DB
    Hosp Cost Manag Account; 1997 May; 9(2):1-6. PubMed ID: 10172989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.